08 Nov 2024
Cummins
Motilal Oswal
3581.90
4300.00
3655.35
(-2.01%)
20.05
Buy
Broker Report
Cummins India’s (KKC) 2QFY25 results exceeded our and consensus estimates, with 31%/42%/37% YoY growth in revenue/EBITDA/PAT.
08 Nov 2024
Escorts Kubota
Motilal Oswal
Target
3429.60
3560.00
3635.50
(-5.66%)
Target met
Neutral
Broker Report
Escorts Kubota’s (ESCORTS) 2QFY25 operating performance was stable YoY as the company reported flattish revenue/EBITDA growth YoY.
07 Nov 2024
Tata Steel
Motilal Oswal
Target
161.36
160.00
150.95
(6.90%)
Target met
Neutral
Broker Report
2QFY25 revenue stood at INR324b (-5% YoY/-2% QoQ), in line with our estimate of INR326. The QoQ decline was due to weak realization.
07 Nov 2024
Gujarat State
Motilal Oswal
Target
323.30
415.00
390.40
(-17.19%)
28.36
Neutral
Broker Report
Gujarat State Petronet (GUJS)’s 2QFY25 EBITDA was 18% below our estimate at INR1.9b, as total volumes came in 13% lower than our estimate.
07 Nov 2024
Clean Science
Motilal Oswal
Target
1246.50
1430.00
1483.60
(-15.98%)
Target met
Neutral
Broker Report
Clean Science (CLEAN)’s reported EBITDA in 2QFY25 was below our estimate at INR897m (+20% YoY), with a gross margin of 62.4% (vs. 65.9% in 2QFY24).
07 Nov 2024
Alembic Pharma
Motilal Oswal
Target
1007.60
1110.00
1079.90
(-6.70%)
Target met
Neutral
Broker Report
Alembic Pharma’s (ALPM) 2QFY25 results came in below our estimates due to the deterioration in API business and higher operational costs.
07 Nov 2024
Aavas Financiers
Motilal Oswal
Target
1759.00
1880.00
1705.90
(3.11%)
Target met
Neutral
Broker Report
AAVAS Financiers (AAVAS)’s 2QFY25 PAT grew 22% YoY to ~INR1.48b (in line). 1HFY25 PAT grew 18% YoY to ~INR2.74b.
07 Nov 2024
Trent
Motilal Oswal
Target
5043.50
8200.00
6505.50
(-22.47%)
62.59
Buy
Broker Report
Trent Ltd (TRENT) continued to buck the weak consumer sentiment trends, delivering robust ~40% YoY revenue (though weaker than 50%+ YoY in the past few quarters) and 46% YoY PAT growth in 2Q.
07 Nov 2024
Page Industries
Motilal Oswal
Reco
Target
48315.00
54000.00
45064.10
(7.21%)
11.77
Buy
Broker Report
Page Industries (PAGE) reported sales growth of 11% in 2QFY25 (est. 7%; 4% in 1Q), with healthy 7% YoY volume growth (est. 3.5%; 3% in 1Q) to 55m.
07 Nov 2024
Max Healthcare
Motilal Oswal
1264.60
1240.00
1078.75
(17.23%)
Target met
Buy
Broker Report
Max Healthcare (MAXH) delivered slightly better-than-expected operational performance in 2QFY25. The annualized EBITDA per bed improved to INR7.8m from INR7.0m QoQ at its existing centers.